Intra-amniotic urea and prostaglandin F2α for midtrimester abortion: Clinical and laboratory evaluation
Authors:
- Theodore M. KingTKTheodore M. King
- Norman H. DubinNDNorman H. Dubin
- Milagros F. AtienzaMAMilagros F. Atienza
- Ronald T. BurkmanRBRonald T. Burkman
- David A. BlakeDBDavid A. Blake
- Nancy A. BarosNBNancy A. Baros
- 1 December 1977
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 129 (7) , 817-823
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intra-amniotic urea and prostaglandin F2α for midtrimester abortion: A modified regimenAmerican Journal of Obstetrics and Gynecology, 1976
- Pharmacokinetics of intra-amniotically administered hyperosmolar urea in rhesus monkeysAmerican Journal of Obstetrics and Gynecology, 1976
- ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTIONThe Lancet, 1975
- Intra-amniotic urea as a midtrimester abortifacient: Clinical results and serum and urinary changesAmerican Journal of Obstetrics and Gynecology, 1975
- The synergistic activity of intra-amniotic prostaglandin F2α and urea in the midtrimester elective abortionAmerican Journal of Obstetrics and Gynecology, 1974
- TECHNIQUES OF PREGNANCY TERMINATION Part IIObstetrical & Gynecological Survey, 1974
- SERUM-ALPHA-FETOPROTEIN LEVELS IN PATIENTS WITH ATAXIA-TELANGIECTASIAThe Lancet, 1972